Neutral and positively charged thiols synergize the effect of the immunomodulator AS101 as a growth inhibitor of Jurkat cells, by increasing its uptake
- 1 September 2007
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 74 (5), 712-722
- https://doi.org/10.1016/j.bcp.2007.05.011
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease modelsThe FASEB Journal, 2007
- The immunomodulator AS101 induces growth arrest and apoptosis in Multiple Myeloma: Association with the Akt/Survivin pathwayBiochemical Pharmacology, 2006
- Organoselenium and Organotellurium Compounds: Toxicology and PharmacologyChemical Reviews, 2004
- Hair growth induction by the tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras‐dependent up‐regulation of KGF expressionThe FASEB Journal, 2003
- Tellurium Compounds: Selective Inhibition of Cysteine Proteases and Model Reaction with ThiolsInorganic Chemistry, 1998
- Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide.Journal of Clinical Oncology, 1995
- A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometryJournal of Immunological Methods, 1991
- Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1.Proceedings of the National Academy of Sciences of the United States of America, 1991
- A new immunomodulating compound (AS-101) with potential therapeutic applicationNature, 1987
- Abnormal trace elements in man: TelluriumJournal of Chronic Diseases, 1967